Skip to search formSkip to main contentSkip to account menu

Treatment Satisfaction Questionnaire for Medication

Known as: TSQM-9, Treatment Satisfaction Questionnaire for Medication (TSQM-9) 
A 9 question subset of the Treatment Satisfaction Questionnaire for Medication that omits the five items of the side effects domain.
National Institutes of Health

Related topics

Related topics

4 relations
Certainty that Good Outweighs the Bad Things About MedicationConvenience of Taking Medication as InstructedSatisfaction with Time it Takes Medication to Start WorkingSatisfaction with Way Medication Relieves Symptoms

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Self-reported satisfaction of patients receiving omalizumab for severe allergic asthma in Malta.
2018
2018
A Prospective, Open-Label Study Evaluating Adjunctive Calcipotriene 0.005%/Betamethasone Dipropionate 0.064% Foam in Psoriasis Patients With Inadequate Response to Biologic Therapy.
OBJECTIVE To assess the effectiveness and safety of combining calcipotriene 0.005%/betamethasone dipropionate 0.064% (Cal/BD… 
2015
2015
Vildagliptin versus insulin in patients with type 2 diabetes mellitus inadequately controlled with sulfonylurea: results from a randomized, 24 week study
Abstract Objective: There is limited evidence to guide the selection of second-line anti-hyperglycemic agents in patients with… 
2015
2015
Patient Satisfaction with Fentanyl Sublingual Spray in Opioid‐Tolerant Patients with Breakthrough Cancer Pain
Breakthrough cancer pain (BTCP) is associated with decreased satisfaction with around‐the‐clock opioid therapy. This analysis… 
2014
2014
Real-life treatment profile of calcipotriene and betamethasone dipropionate topical suspension in patients with psoriasis vulgaris.
BACKGROUND Treatment with calcipotriene plus betamethasone dipropionate (CBD) fixed-combination topical suspension has been shown… 
Review
2012
Review
2012
Psychometric Properties of the Osteoporosis-Specific Morisky Medication Adherence Scale in Postmenopausal Women with Osteoporosis Newly Treated with Bisphosphonates
Background: Poor adherence to oral osteoporosis medications is common. Strategies for improving adherence begin with… 
2012
2012
Etanercept Improves Quality of Life Outcomes and Treatment Satisfaction in Patients with Moderate to Severe Plaque Psoriasis in Clinical Practice
Background: Etanercept is well tolerated and effective in moderate to severe psoriasis; however, data on patient-reported… 
2012
2012
Study Design and First Results of a Non-Interventional Registry Study To Establish Long-Term Safety and Pharmaco-Economic Data on Fingolimod (Gilenya(R)) in Multiple Sclerosis Patients in Germany…
Objective: In order to investigate the safety and efficacy of fingolimod (Gilenya®) in everyday clinical practice, a 4000-patient… 
2012
2012
Self-medication of upper gastrointestinal symptoms with hydrotalcite: a noninterventional community pharmacy study on drug usage and patient satisfaction.
OBJECTIVE Acid-related gastrointestinal symptoms are widely prevalent. These complaints are often self-medicated with antacids… 
2008
2008
Abstracts from the ASENT 2008 Annual Meeting March 6–8, 2008
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)